Placental thrombosis and second trimester miscarriage in association with activated protein C resistance

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 8, 1996, Pages 842-844

  Rai, R S ^a   Regan, L ^a   Chitolie, A ^b   Donald, J G ^c   Cohen, H ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c PERTH ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; HEPARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; FEMALE; HISTOLOGY; HUMAN; PLACENTA DISORDER; PRIORITY JOURNAL; RECURRENT ABORTION; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; THROMBOPHILIA; THROMBOSIS;

ABORTION, HABITUAL; ADULT; ASPIRIN; BLOOD COAGULATION DISORDERS; FACTOR XA; FEMALE; HUMANS; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROTEIN C; THROMBOSIS;

EID: 0029780369     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09887.x     Document Type: Article

References (8)

1. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994; 9: 1328–1332.
2. Rai RS, Regan L, Hadley E, Dave M, Cohen H. Second trimester pregnancy loss is associated with activated protein C resistance. Br J Haematol 1996; 92: 489–490.
3. Bertina RM, Koeleman BP, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64–67.
4. Harris EN. Syndrome of the black swan. Br J Rheumatol 1987; 26: 324–326.
5. Dahlbäck B., Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004–1008.
6. Cumming AM, Tait RC, Fildes S, Yoong, A, Keeney S, Hay CRM. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995; 90: 125–127.
7. Melissari E, Parker CJ, Wilson NV et al. Use of low molecular weight heparin in pregnancy. Thromb Haemost 1992; 68:652–656.
8. Stirling D, White A, Clarkson J. Importance of both functional and genetic testing for diagnosis of activated protein C resistance (abstract). Thromb Haemost 1995; 73: 1365.